Northwest Biotherapeutics, Inc. (NWBO)
0.236
0.00 (0.00%)
USD |
OTCM |
Dec 12, 15:58
Northwest Biotherapeutics EPS Diluted (Quarterly): -0.0182 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.83M |
| Revenue (Quarterly) | 0.20M |
| Total Expenses (Quarterly) | 27.03M |
| Enterprise Value | 444.10M |
| Gross Profit Margin (Quarterly) | -160.5% |
| Profit Margin (Quarterly) | -13.41K% |
| Earnings Yield | -27.88% |
| Normalized Earnings Yield | -24.24 |